Waqar M. Haque, MD

Assistant Professor of Clinical Radiation Oncology, Institute for Academic Medicine
Assistant Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Haque is a native Houstonian and attended medical school at Baylor College of Medicine. He graduated in 2010 as a member of the Alpha Omega Alpha Medical Honor Society.  He completed residency in radiation oncology at the University of Texas Medical Branch in Galveston, during which he also spent time training at the MD Anderson Cancer Center.

Publications

Pathologic nodal clearance and complete response following neoadjuvant chemoradiation for clinical N2 non-small cell lung cancer: Predictors and long-term outcomes
Haque, WM, Verma, V, Butler, EB & Teh, BS 2019, Lung Cancer, vol. 130, pp. 93-100. https://doi.org/10.1016/j.lungcan.2019.02.003

Postmastectomy radiation therapy for triple negative, node-negative breast cancer
Haque, WM, Verma, V, Farach, AM, Butler, EB & Teh, BS 2019, Radiotherapy and Oncology, vol. 132, pp. 48-54. https://doi.org/10.1016/j.radonc.2018.11.012

Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma
Haque, WM, Arms, A, Verma, V, Hatch, S, Brian Butler, E & Teh, BS 2019, Breast, vol. 43, pp. 67-73. https://doi.org/10.1016/j.breast.2018.11.007

Reply to the letter “Pure or mixed type invasive lobular carcinoma; are they different from each other?”
Haque, WM & Teh, BS 2019, Breast, vol. 43, pp. 151-152. https://doi.org/10.1016/j.breast.2018.12.006

Post-treatment mortality after definitive chemoradiotherapy versus trimodality therapy for locally advanced non-small cell lung cancer
Haque, WM, Verma, V, Butler, EB, Teh, BS & Rusthoven, CG 2019, Lung Cancer, vol. 127, pp. 76-83. https://doi.org/10.1016/j.lungcan.2018.11.026

Stereotactic radiosurgery for brain metastases from newly diagnosed small cell lung cancer: practice patterns and outcomes
Jiang, W, Haque, WM, Verma, V, Butler, EB & Teh, BS 2019, Acta Oncologica. https://doi.org/10.1080/0284186X.2018.1562207

Survival Outcomes and Patterns of Management for Anal Adenocarcinoma
Lewis, GD, Haque, WM, Butler, EB & Teh, BS 2019, Annals of Surgical Oncology. https://doi.org/10.1245/s10434-019-07202-4

Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States
Haque, WM, Verma, V, Butler, EB & Teh, BS 2019, Journal of Immunotherapy. https://doi.org/10.1097/CJI.0000000000000264

Sequencing of Chemotherapy and Radiotherapy for Newly Diagnosed Anaplastic Oligodendroglioma and Oligoastrocytoma
Ryckman, JM, Surkar, SM, Haque, WM, Butler, EB, Teh, BS & Verma, V 2019, American Journal of Clinical Oncology: Cancer Clinical Trials. https://doi.org/10.1097/COC.0000000000000511

A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors
Verma, V, Sprave, T, Haque, WM, Simone, CB, Chang, JY, Welsh, JW & Thomas, CR 2018, Journal for ImmunoTherapy of Cancer, vol. 6, no. 1, 128, pp. 128. https://doi.org/10.1186/s40425-018-0442-7

Omission of chemotherapy for low-grade, luminal A N1 breast cancer: Patterns of care and clinical outcomes
Haque, WM, Verma, V, Hatch, S, Klimberg, VS, Butler, EB & Teh, BS 2018, Breast, vol. 41, pp. 67-73. https://doi.org/10.1016/j.breast.2018.06.014

Postoperative chemoradiotherapy versus radiotherapy alone for elderly cervical cancer patients with positive margins, lymph nodes, or parametrial invasion
Cushman, TR, Haque, WM, Menon, H, Rusthoven, CG, Butler, EB, Teh, BS & Verma, V 2018, Journal of gynecologic oncology, vol. 29, no. 6, e97, pp. e97. https://doi.org/10.3802/jgo.2018.29.e97

Trends and disparities in the utilization of hypofractionated neoadjuvant radiation therapy for rectal cancer in the United States
Haque, W, Verma, V, Butler, EB & Teh, BS 2018, Journal of Gastrointestinal Oncology, vol. 9, no. 4, pp. 601-609. https://doi.org/10.21037/jgo.2018.05.08

Utilization of intensity modulated radiation therapy for anal cancer in the United States
Haque, WM, Verma, V, Butler, EB & Teh, BS 2018, Journal of Gastrointestinal Oncology, vol. 9, no. 3, pp. 466-477. https://doi.org/10.21037/jgo.2018.03.03

Utilization of hysterectomy following chemoradiation for IB2/IIA2 cervical cancer in the national cancer data base
Haque, WM, Verma, V, Butler, EB & Teh, BS 2018, Anticancer Research, vol. 38, no. 5, pp. 3175-3179. https://doi.org/10.21873/anticanres.12581

Sequential versus concurrent chemoradiation therapy by surgical margin status in resected non-small cell lung cancer
Verma, V, Moreno, AC, Haque, WM, Fang, P & Lin, SH 2018, JNCCN Journal of the National Comprehensive Cancer Network, vol. 16, no. 5, pp. 508-516. https://doi.org/10.6004/jnccn.2018.7007

Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy
Haque, WM, Verma, V, Hatch, S, Suzanne Klimberg, V, Butler, EB & Teh, BS 2018, Breast Cancer Research and Treatment, pp. 1-9. https://doi.org/10.1007/s10549-018-4801-3

Utilization of radiotherapy and stereotactic body radiation therapy for renal cell cancer in the USA
Haque, WM, Verma, V, Lewis, GD, Lo, SS, Butler, EB & Teh, BS 2018, Future Oncology, vol. 14, no. 9, pp. 819-827. https://doi.org/10.2217/fon-2017-0536

Omission of radiotherapy in elderly women with early stage metaplastic breast cancer
Haque, W, Verma, V, Butler, EB & Teh, BS 2018, Breast, vol. 38, pp. 154-159. https://doi.org/10.1016/j.breast.2018.01.005

Utilization of neoadjuvant intensity-modulated radiation therapy and proton beam therapy for esophageal cancer in the United States
Haque, WM, Verma, V, Butler, EB & Teh, BS 2018, Journal of Gastrointestinal Oncology, vol. 9, no. 2, pp. 282-294. https://doi.org/10.21037/jgo.2017.11.14

Live Chat Available